These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1586902)

  • 1. Hypoglycemic drugs.
    White JR; Campbell RK
    Clin Podiatr Med Surg; 1992 Apr; 9(2):239-55. PubMed ID: 1586902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypoglycemic sulfamides: new pharmacologic data and practical implications].
    Blickle JF; Brogard JM
    Diabetes Metab; 1998 Jun; 24(3):276-80. PubMed ID: 9690064
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral hypoglycemic agents in the treatment of type II diabetes.
    Tal A
    Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in diabetes care and management.
    Figge J; Figge HL
    Clin Orthop Relat Res; 1993 Nov; (296):31-6. PubMed ID: 8222444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
    Ponte CD
    W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin in the early management of diabetic complications.
    Miles JM
    J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving post-prandial control with Humalog and Humalog mixtures.
    Lüddeke HJ
    Int J Clin Pract Suppl; 2000 Sep; (112):23-8. PubMed ID: 11064948
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
    Graham JP; Stam D
    Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting diabetes management regimens in response to illness.
    Dromgoole P
    Prof Nurse; 2005 Jan; 20(5):34-6. PubMed ID: 15682995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidiabetic agents.
    Francisco GE
    Prim Care; 1990 Sep; 17(3):499-519. PubMed ID: 2236334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic treatment of diabetes].
    De Montigny P; Clerc C; Descarpentries C
    Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
    [No Abstract]   [Full Text] [Related]  

  • 16. Tube feeding your diabetic patient safely.
    Bak LB; Heard KA; Kearney GP
    Am J Nurs; 1996 Dec; 96(12):47-9. PubMed ID: 8961863
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin treatment of Type II diabetes].
    Berger W; Waeber C; Tatti V
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1233-6. PubMed ID: 2237054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Aug; 29(8):1990-1. PubMed ID: 16873829
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
    Farooki A; Schneider SH
    Diabetes Care; 2006 Aug; 29(8):1989-90. PubMed ID: 16873827
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.